Prevalence of clinical characteristics according to phenotype in pediatric and adult patients with CAH due to 21-hydroxylase deficiency. A, BMI. B, BP, SBP, and DBP. C, Insulin resistance based on HOMA-IR (13); pediatric includes adolescents (≥13 yr). D, BMD; pediatric includes those at least 8 yr old.